Almost Family Inc (AFAM) 42.11 $AFAM Almost Family, Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 7:19 AM

Almost Family Inc (AFAM) 42.11 $AFAM

Almost Family, Inc. to Present at the Jefferies Healthcare Conference
GlobeNewswire - Tue Jun 07, 7:32AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that Steve Guenthner, President and Principal Financial Officer is scheduled to present at the Jefferies Healthcare Conference in New York City.
AFAM: 42.11 (-0.81)

Almost Family Announces Home Health Entry into The State of Wisconsin
GlobeNewswire - Wed May 25, 7:30AM CDT
Almost Family, Inc. (NASDAQ:AFAM), today announced that it has entered into a transaction for entry into the State of Wisconsin through the acquisition of certain home health agency assets from ResCare Inc. Annualized revenues of $15 million, principally for personal care services, are expected to be generated across 8 branches in Wisconsin.
AFAM: 42.11 (-0.81)

DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.43 (-0.66), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13), HLS: 40.54 (-1.02)

Quest Diagnostics (DGX) Divests Focus, Cuts Sales View
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:44AM CDT
Quest Diagnostics Inc. (DGX) has updated its outlook for 2016 following the completion of the sale of Focus Diagnostics Inc.
AFAM: 42.11 (-0.81), LHCG: 42.75 (-0.78), DGX: 77.45 (-1.30), HLS: 40.54 (-1.02)

BioScrip (BIOS) Q1 Loss Wider than Expected, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:11AM CDT
BioScrip, Inc. (BIOS) reported net loss from continuing operations of 17 cents per share in the first quarter of 2016.
USPH: 59.40 (-0.25), AFAM: 42.11 (-0.81), BIOS: 2.83 (-0.10), HLS: 40.54 (-1.02)

Almost Family, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Mon May 09, 8:14AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that Steve Guenthner, President and Principal Financial Officer is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, Nevada.
AFAM: 42.11 (-0.81)

Amedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:56AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 33 cents per share in the first quarter of 2016.
BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)

Almost Family Reports First Quarter 2016 Results
GlobeNewswire - Wed May 04, 6:30AM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today its financial results for the quarter ended April 1, 2016.
AFAM: 42.11 (-0.81)

Almost Family, Inc. to Report First Quarter 2016 Financial Results on May 4, 2016
GlobeNewswire - Mon May 02, 6:18PM CDT
Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that it will report financial results for its first quarter 2016 on Wednesday, May 4, 2016, publishing an earnings release before the market opens.
AFAM: 42.11 (-0.81)

Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 132.09 (-1.78), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)

Quest Diagnostics (DGX) Q1 Earnings in Line, Volume Up
Zacks Equity Research - Zacks Investment Research - Thu Apr 21, 8:23AM CDT
Quest Diagnostics' (DGX) first-quarter 2016 adjusted earnings per share (EPS) of $1.12 came in line with the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), DGX: 77.45 (-1.30), AMED: 51.80 (-1.00)

AmSurg Poised on Strategic Buyouts, Rising Costs a Concern
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 4:46PM CDT
On Apr 18, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00)

3 Reasons Value Stock Investors Will Love Almost Family (AFAM)
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 8:16AM CDT
Almost Family looks great given its impressive metrics and estimate revisions
AFAM: 42.11 (-0.81)

Amedisys Poised on Balanced Growth, Strategic Buyouts
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 1:35PM CDT
On Apr 11, 2016, we issued an updated research report on Amedisys Inc. (AMED).
AFAM: 42.11 (-0.81), CSII: 18.36 (+0.41), RMD: 59.80 (-0.70), AMED: 51.80 (-1.00)

DaVita to Acquire Mountain View, Expand Footprint in Colorado
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 1:35PM CDT
DaVita HealthCare Partners Inc. (DVA) intends to acquire Mountain View Medical Group to enhance its kidney care services and extend footprint in Colorado Springs.
ABUS: 3.60 (-0.33), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13), AMED: 51.80 (-1.00)

Strength Seen in Amedisys (AMED): Stock Soars 14.7%
Zacks Equity Research - Zacks Investment Research - Thu Mar 10, 7:00AM CST
Amedisys (AMED) was a big mover last session with its shares rising roughly 15% on the day.
AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00)

3 Cheap Growth Stocks You Can Buy Right Now
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 10, 6:03AM CST
Image source: StockMonkeys.com via Flickr. When the stock market was in nearly nonstop rally mode for most of the past six years, investors didn't need to look far to uncover an abundance of growth stocks. But not all growth stocks are created...
CAL: 24.74 (-0.23), BIDU: 164.28 (-4.71), AFAM: 42.11 (-0.81)

DaVita Closes Everett Buyout, Continues Inorganic Growth
Zacks Equity Research - Zacks Investment Research - Wed Mar 02, 2:55PM CST
DaVita HealthCare Partners (DVA) announced the timely completion of its acquisition of The Everett Clinic.
HCA: 79.55 (-1.48), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13)

New Strong Buy Stocks for February 9th
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
AGTC: 15.49 (-0.51), ACHC: 61.55 (-1.43), ACAS: 15.97 (-0.04), AFAM: 42.11 (-0.81), ADSK: 56.18 (-1.61)

Almost Family, Citigroup and GoPro, highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 8:30AM CST
Almost Family, Citigroup and GoPro, highlighted as Zacks Bull and Bear of the Day
GPRO: 10.26 (-0.64), AFAM: 42.11 (-0.81), C: 43.90 (-1.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pyxus Starts Exchange Offer for 8.50% Notes, 2027

Pyxus Restructures Via Exchange Offer Pites, it's time for Pyxus International to show its hand. The global agricultural player has rolled up its sleeves, kicking off an exchange offer for its 8.50% notes maturing in 2027. With $148.3 million hanging in the balance, this move is their shot at managing debt and keeping things steady—like a farmer making sure the...

Nevada Organic Phosphate Cancels Share Consolidation Plan

Unexpected Turn for Nevada Organic Phosphate In an abrupt twist that surprised some investors, Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) (FSE: ZV8), the Canadian trailblazer in organic phosphate mining, called off its proposed share consolidation. Dropping the plan wasn't just a stroke of luck; it came after hearing the grumblings of shareholders concerned...

Inner City Visions Celebrates Two Decades of Impact

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Elong Kicks Off Central Asia Strategy with Almaty Launch

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

PMET's High-Stakes Call on Shaakichiuwaanaan Update

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

GFL Stays Public: Board Sees Growth Beyond Buyout

GFL Environmental Says 'No Thanks' to Takeover Bids Wall Street loves a juicy M&A story, but GFL Environmental decided it’s not playing ball. In a world where companies seem to flip like properties on a hot market, GFL has boldly told prospective buyers to buzz off. They want to stay public, continue carving their path without the trappings of private equity overlords....

HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

First Graphene Taps Deeper into US Defense Market

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Solar Cooking Revolution: InventHelp's Latest Innovation

A Bright Idea Shines with Solar Cooking Some days, you stumble across an idea that just seems destined to shake things up, and COOK SOL SOLAR POWER COOKER might just be one of those spark plugs ready to ignite the world of outdoor cooking. Invented by a plucky thinker from Florence, South Carolina, this little gadget isn't just about frying up eggs on a camping trip. Nah,...